Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 9
Submit an article Journal homepage
524
Views
6
CrossRef citations to date
0
Altmetric
Review

Recent advances in glucose-lowering treatment to reduce diabetic kidney disease

Nordin MJ HanssenMaastricht University, CARIM School of Cardiovascular Diseases, Department of Internal Medicine, Maastricht, The Netherlands;Diabetes Domain, Baker IDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria, 3004, Australia+61 3 8532 1151; +61 3 8532 1480; [email protected]
,
Nicholas RussellDiabetes Domain, Baker IDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria, 3004, Australia+61 3 8532 1151; +61 3 8532 1480; [email protected];Austin Health, Heidelberg, Melbourne, Australia
&
Mark E CooperDiabetes Domain, Baker IDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, Victoria, 3004, Australia+61 3 8532 1151; +61 3 8532 1480; [email protected]
, MBBS PhD FRACP
Pages 1325-1333 | Published online: 26 Apr 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jingbo Hu & Yongzhong Du. (2019) Managing chronic kidney disease in diabetes patients with the latest chemical therapies. Expert Review of Clinical Pharmacology 12:1, pages 53-60.
Read now

Articles from other publishers (5)

Hufeng Fang, Shan Xu, Yu Wang, Hao Yang & Dan Su. (2023) Endogenous stimuli-responsive drug delivery nanoplatforms for kidney disease therapy. Colloids and Surfaces B: Biointerfaces 232, pages 113598.
Crossref
Yaxun Li, Guoqin Feng, Jiajia Liu, Tingting Yang, Ruxia Hou, Junyu Liu & Xiangyu Wang. (2023) Progress in Glucose‐Sensitive Hydrogels for Biomedical Applications. Macromolecular Chemistry and Physics 224:23.
Crossref
Meng-Qi Tong, Lan-Zi Luo, Peng-Peng Xue, Yong-Hui Han, Li-Fen Wang, De-Li Zhuge, Qing Yao, Bin Chen, Ying-Zheng Zhao & He-Lin Xu. (2021) Glucose-responsive hydrogel enhances the preventive effect of insulin and liraglutide on diabetic nephropathy of rats. Acta Biomaterialia 122, pages 111-132.
Crossref
Paola Fioretto & Andrea Frascati. (2018) Role of incretin based therapies in the treatment of diabetic kidney disease. Diabetes mellitus 21:5, pages 395-398.
Crossref
Kunz Martinez Walter & Perez Pacheco Arturo Ivan. (2018) The privileged position of glp-1 in diabetic nephropathy. Endocrinology&Metabolism International Journal 6:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.